Posts by devx
Expanding access to tuberculosis care using PodTech™s modular facilities
Despite spectacular advances in biopharmaceutical research, drug development and overall quality of life over the past few decades, tuberculosis remains a stain on global health progress. 8.2 million people were newly diagnosed with tuberculosis (TB) in 2023. That number is not only a notable increase from the 7.5 million reported the year prior, but…
Read MoreEnabling climate resilience with PodTech™
Human health is inextricably linked with environmental health in more ways than you think. Beyond the direct health impacts of extreme weather events like floods and heatwaves, there are several indirect impacts that affect people’s health and overall quality of life. A World Economic Forum report titled Quantifying the Impact of Climate Change on…
Read MoreAll you need to know about off-site modular fabrication of biopharma manufacturing facilities
As the biopharma industry becomes more technologically advanced, it is also driving the demand for innovative solutions to optimise drug development costs. It is demanding improvements in the construction delivery process. And it is demanding that the trickle-down effects of these advances reach every person in the world. In other words, as the biopharma…
Read MoreModular cleanrooms to democratise biopharma development and healthcare access
Cleanrooms are classified enclosed spaces within which controlled environmental conditions are maintained to minimise the presence of airborne and other contaminants. Air handling and other environmental control systems are used to maintain the required temperature, pressure, humidity, air filtration, etc. Given the stringent demand for controlled hygienic environments while making drugs, vaccines and other health…
Read MoreWhat to look for in a prefab pharma factory solutions provider
Setting up a biopharmaceutical manufacturing facility is a significant investment. From acquiring land and building a structure that meets all regulatory standards to equipping it with the right machines, setting standard operating procedures, procuring inputs and training your staff, there’s no dearth of pressures on your time, effort and budget. Outsourcing an important part…
Read MoreWhy prefabricated pharmaceutical factories? The benefits of prefabrication over traditional construction for the biopharma sector
Making medicines, vaccines, diagnostics and other health products isn’t a concern for only the discipline of biochemistry. Developing, producing, distributing and consuming these products entails the coming together of multiple activities, sectors and industries – from basic scientific research to clinical trials, from governmental regulations to business environments, from health and advocacy to packaging and…
Read MoreConcept of scale: PodTech™ to aid quick scaling up of facilities and infrastructure
Since GLP-1 receptor agonist drugs came on the market to treat obesity and diabetes, their popularity has been unprecedented. As often happens in such situations, the massive demand for these treatments resulted in a chronic supply shortage – one that will persist until manufacturers’ investments in scaling production begin to bear fruit. So high…
Read MoreExpand HPV vaccine access with PodTech™
Did you know that one in every five children who loses their mother to cancer does so due to cervical cancer? Cervical cancer is the 4th most common cancer among women globally. As many as 660,000 new cases and 350,000 deaths from cervical cancer were reported in 2022. As with many other diseases, the…
Read MoreHow PodTech™ helps with regulatory challenges in emerging markets
If you follow health sector news from Africa, South Asia, Latin America or even the United States, every now and then, you’ll come across a story about a product recall or adverse impacts patients have suffered from consuming substandard or fake medications. Beyond drug quality issues, there are also concerns about insufficient supply or inaccessibility…
Read MoreThe last leg of the fight against HIV
On 9 June 2021, the United Nations Member States adopted a declaration related to HIV diagnosis, treatment and care. The political declaration called on countries to achieve the 95-95-95 targets by 2025. 95% of people living with HIV should know their HIV status. 95% of people who know their HIV status should be receiving antiretroviral…
Read More